Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.049 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.066 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.1 | 0.7 |